This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
4 Reasons to Invest in Civista Bancshares (CIVB) Stock Now
by Zacks Equity Research
Driven by strong fundamentals and good growth prospects, Civista Bancshares (CIVB) stock seems to be an attractive investment option right now.
4 Reasons to Invest in Credit Acceptance (CACC) Stock Now
by Zacks Equity Research
Driven by strong fundamentals and good growth prospects, Credit Acceptance (CACC) seems to be a solid bet now.
4 Reasons to Add Ares Capital (ARCC) Stock to Your Portfolio
by Zacks Equity Research
Driven by strong fundamentals and good growth prospects, Ares Capital (ARCC) seems to be a solid bet now.
Zacks.com featured highlights include: Ready Capital, Gladstone, NeoGenomics, Digi and Paramount
by Zacks Equity Research
Zacks.com featured highlights include: Ready Capital, Gladstone, NeoGenomics, Digi and Paramount
Gladstone Investment (GAIN) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Gladstone Investment (GAIN) have what it takes to be a top stock pick for momentum investors? Let's find out.
5 Breakout Stocks for Stellar Returns
by Swarup Gupta
This method involves zeroing in on stocks whose prices vary within a narrow band.
Gladstone Investment (GAIN) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Gladstone Investment (GAIN) delivered earnings and revenue surprises of 33.33% and 5.12%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Gladstone Investment (GAIN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Gladstone Investment (GAIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gladstone Investment (GAIN) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Gladstone Investment (GAIN) delivered earnings and revenue surprises of -50.00% and -14.83%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Gladstone Investment (GAIN) Q2 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
Gladstone Investment (GAIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gladstone Investment (GAIN) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Gladstone Investment (GAIN) delivered earnings and revenue surprises of 5.26% and 2.30%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Display Strength Aid Applied (AMAT) in Q2 Earnings?
by Zacks Equity Research
Applied Materials' (AMAT) technology leadership position and strong product line in Display and Services might aid results.
Should You Sell Gladstone Investment (GAIN) Before Earnings?
by Zacks Equity Research
Gladstone Investment (GAIN) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.
Will New Technologies Benefit Agilent (A) in Q2 Earnings?
by Zacks Equity Research
Agilent Technologies' (A) leadership position and strength in revenue segments are likely to aid results. However, macro weakness in some regions may impact Q2 earnings of the company.
Why GAIN Capital Holdings (GAIN) Might Surprise This Earnings Season
by Zacks Equity Research
GAIN Capital Holdings (GAIN) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to earnings beat.
Explosive Stocks Under $10
by Kevin Matras
Kevin Matras looks for stocks under $10 with explosive potential. Highlighted stocks include ABR, AFFX, GAIN, ORBC and SIRI.
The Power of New Analyst Coverage
by Kevin Matras
Kevin Matras shows why stocks with new analyst coverage are stocks you want to have. Highlighted stocks include CINF, GAIN, NEOG, CCRN and TYL.